- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GIKAVI
Total 48 results
-
Zuyderland Medisch CentrumRecruitingQuality of Life | Gastric Cancer | Esophageal Cancer | Vitamin DiseaseNetherlands
-
French Innovative Leukemia OrganisationCompleted
-
Columbia UniversityLocks of Love; Alopecia Areata Initiative - Gates FoundationCompletedAlopecia AreataUnited States
-
Novartis PharmaceuticalsRecruitingGraft-versus-Host DiseaseKorea, Republic of
-
Yi-Lun WangCompletedSteroid Refractory GVHDTaiwan
-
Novartis PharmaceuticalsNovartis is the Marketing Authorization Holder for Jakavi outside the US.No longer availableSevere/Very Severe COVID-19 Illness
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
The Lymphoma Academic Research OrganisationNovartisCompletedHodgkin's LymphomaFrance, Belgium
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisGermany
-
Novartis PharmaceuticalsAvailable
-
Columbia UniversityIncyte CorporationActive, not recruitingAdvanced Cutaneous Squamous Cell CarcinomaUnited States
-
University Health Network, TorontoTerminatedCOVID-19 | PneumoniaCanada
-
Oncology Institute of Southern SwitzerlandWithdrawn
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, China, Japan, France, Turkey, Germany, Israel, Poland, Belgium, Italy, Austria, Denmark, Finland, Norway
-
Novartis PharmaceuticalsCompleted
-
Kartos Therapeutics, Inc.RecruitingMyelofibrosisUnited States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, Belgium, France, Israel, China, Japan, Italy, Germany, Taiwan, Poland, Austria, Finland, Hungary, Norway, Romania, Turkey
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Netherlands, Austria
-
University Health Network, TorontoNovartisCompletedChronic Phase Chronic Myeloid Leukemia | Philadelphia Positive Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blastic Phase Chronic Myeloid Leukemia | Resistant to Tyrosine Kinase Inhibitor TherapyCanada
-
Universitätsklinikum Hamburg-EppendorfNovartis; Clinical Trial Center North (CTC North GmbH & Co. KG)Active, not recruitingBone Marrow FibrosisGermany
-
Novartis PharmaceuticalsCompletedPolycythemia Vera (PV)United States
-
Telios Pharma, Inc.RecruitingPrimary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET MyelofibrosisSpain, United States, France, Poland, Italy, Germany
-
Novartis PharmaceuticalsActive, not recruitingMyelofibrosisUnited Kingdom, Australia, Canada, Switzerland, Netherlands, Spain, Germany, Italy, Turkey, Russian Federation, Sweden, Denmark, Hungary
-
University Hospital, Clermont-FerrandUnknownCancer | FertilityFrance
-
Incyte CorporationTerminatedCRC (Colorectal Cancer)United States, France, United Kingdom, Spain, Israel, Australia, Germany, Korea, Democratic People's Republic of
-
University of LuebeckCompleted
-
University Hospital, Clermont-FerrandRecruitingFertility | Assisted Reproductive Technology | Vitrification | Egg DonorFrance
-
Incyte CorporationTerminatedBreast CancerUnited States, France, United Kingdom, Spain, Italy, Portugal
-
Washington University School of MedicineTakedaTerminatedMyelofibrosesUnited States
-
Incyte CorporationTerminatedPancreatic CancerUnited States, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Korea, Republic of, Canada, New Zealand, Australia, Thailand
-
Incyte CorporationTerminatedPancreatic CancerUnited States, France, Colombia, Israel, Portugal, Netherlands, Chile, Puerto Rico, Sweden, Austria, Denmark, Mexico, Ireland, Switzerland
-
RWTH Aachen UniversityNovartis PharmaceuticalsActive, not recruitingPolycythemia Vera (PV) | Essential Thrombocythemia (ET)Germany
-
University Health Network, TorontoRecruitingMyelofibrosis | Bone Marrow Cancer | High-Risk CancerCanada
-
Teva Pharmaceuticals USACompletedHealthyUnited States
-
Novartis PharmaceuticalsRecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Thalassemia | Graft Versus Host DiseaseKorea, Republic of, Italy, Belgium, Japan, Germany, Australia, Bulgaria, Chile, China, Denmark, Greece, Hungary, Israel, Lebanon, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, Sweden, Thailand, India, Mexico, Turkey, Fran...
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Assistance Publique Hopitaux De Marseille; Hôpital d'instruction des armées...Terminated
-
French Innovative Leukemia OrganisationCompleted
-
Teva Pharmaceuticals USACompletedHealthyUnited States
-
French Innovative Leukemia OrganisationNovartis PharmaceuticalsTerminatedEssential ThrombocythemiaFrance
-
St. Petersburg State Pavlov Medical UniversityActive, not recruitingAcute Myeloid Leukemia | Acute Lymphoid Leukemia | Stem Cell Transplant Complications | Graft-versus-host-diseaseRussian Federation
-
University of BirminghamNovartis; National Cancer Institute, France; MPN VoiceRecruitingPolycythemia VeraUnited Kingdom
-
OncotherapeuticsIncyte CorporationRecruitingMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Endometrial Adenocarcinoma | Recurrent Endometrial Carcinoma | Recurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Mixed Cell Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated... and other conditionsUnited States